Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C

Technology appraisal guidance
Reference number: TA75
Published: 28 January 2004
Last updated: 27 November 2013

TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon: Appendix A - provisional matrix of stakeholders

TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon: Appendix A - provisional matrix of stakeholders

TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon: Appendix A - provisional matrix of stakeholders
14 October 2013
(100.31 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 09 October 2013